Menu: Home :: go to Journal :: switch to Russian :: switch to English
You are here: all Journals and Issues→ Journal→ Issue→ Article

CYBERKNIFE THERAPY OF METASTATIC BRAIN TUMORS AT LUNG CANCER: CLINICAL CASE

Annotation

Brain metastasis is observed among 20-40 % patients, having malignant tumors. The lung cancer is more often source of metastasis. Clinical presentations of metastatic affection are often developing for some weeks, and only in 25 % of cases they are of sudden nature. The length of patient’s life without treatment is one month. After whole-body irradiation of brain the survival of patients is increasing for 4-6 month. Surgical method of treatment is applied at single metastasis in brain at middle size of tumor of 3.43 cm. CyberKnife shows special benefits in the plan of accurate target dose delivery and control over tumors. Its implementation provides the length of life for about 56 weeks. The authors describe the possibilities of implementation of CyberKnife at treatment of multiple, coherence of the appearing metastasis in brain at small cell carcinoma of lung of men 50 year old. The general survivability was 19 months.

Keywords

lungs cancer; metastasis in brain; CyberKnife

Full-text in one file

Download

UDC

616-006

Pages

1699-1703

References

1. Lu-Emerson C., Eichler A.F. Brain metastases // Continuum. 2012. V. 18. P. 295-311. 2. Soffietti R., Ducati A., Rudà R. Brain metastases // Handb. Clin. Neurol. 2012. V. 105. P. 747-755. 3. DeAngelis L.M., Mandell L.R., Thaler H.T., Kimmel D.W., Gali- cich J.H., Fuks Z., Posner J.B. The role of postoperative radiotherapy after resection of single brain metastases // Neurosurgery. 1989. V. 24. P. 798-805. 4. Shimamoto S., Inoue T., Shiomi H., Sumida I., Yamada Y., Tanaka E., Inoue T. CyberKnife stereotactic irradiation for metastatic brain tumors // Radiat. Med. 2002. V. 20. P. 299-304 5. Smedby K.E., Brandt L., Bäcklund M.l., Blomqvist P. Brain metastases admissions in Sweden between 1987 and 2006 // Br. J. Cancer. 2009. V. 101. P. 1919-1924. 6. Bellati F., Palaia I., Gasparri M.L., Musella A., Panici P.B. First case of isolated vaginal metastasis from breast cancer treated by surgery // BMC Cancer. 2012. V. 12. P. 479. 7. Khan E., Ismail S., Muirhead R. Incidence of symptomatic brain metastasis following radical radiotherapy for non-small cell lung cancer: is there a role for prophylactic cranial irradiation? // Br. J. Radiol. 2012. V. 85. P. 1546-1550. 8. Bindal R.K., Sawaya R., Leavens M.E., Lee J.J. Surgical treatment of multiple brain metastases // J. Neurosurg. 1993. V. 79. P. 210-216. 9. Siomin V.E., Vogelbaum M.A., Kanner A.A., Lee S.Y., Suh J.H., Bar- nett G.H. Posterior fossa metastases: risk of leptomeningeal disease when treated with stereotactic radiosurgery compared to surgery // J. Neurooncol. 2004. V. 67. P. 115-121. 10. Lassen B., Helseth E., Rønning P., Scheie D., Johannesen T.B., Mæhlen J., Langmoen I.A., Meling T.R. Surgical mortality at 30 days and complications leading to recraniotomy in 2630 consecutive crani-otomies for intracranial tumors // Neurosurgery. 2011. V. 68. P. 1259-1269. 11. Mayahara H., Sumi M., Ito Y., Sekii S., Takahashi K., Inaba K., Kuro- da Y., Murakami N., Morota M., Itami J. Effect of chemotherapy on survival after whole brain radiation therapy for brain metastases: a single-center retrospective analysis // J. Cancer Res. Clin. Oncol. 2012. V. 138. P. 1239-1247. 12. Rades D., Kueter J.D., Veninga T., Gliemroth J., Schild S.E. Whole brain radiotherapy plus stereotactic radiosurgery (WBRT+SRS) versus surgery plus whole brain radiotherapy (OP+WBRT) for 1–3 brain me-tastases: results of a matchedpair analysis // Eur. J. Cancer. 2009. V. 45. P. 400-404. 13. Serizawa T., Hirai T., Nagano O., Higuchi Y., Matsuda S., Ono J., Saeki N. Gamma knife surgery for 1–10 brain metastases without prophylactic whole-brain radiation therapy: analysis of cases meeting the Japanese prospective multi-institute study (JLGK0901) inclusion criteria // J. Neurooncol. 2010. V. 98. P. 163-167. 14. Bychkov M.B., Gorbunova V.A., Naskhletashvili D.R. i dr. Khimio- i khimioluchevaya terapiya metastazov nekotorykh zlokachestvennykh opukholey v golovnoy mozg // Materialy 10 Rossiyskogo onkologi-cheskogo kongressa. M., 2006. S. 125-128. 15. Voynarevich A.O. Metastaticheskoe porazhenie tsentral'noy nerv-noy sistemy u onkologicheskikh bol'nykh (klinika, diagnostika, korrigiruyushchaya terapiya): avtoref. dis. … d-ra med. nauk. M., 1990. 16. Shchigolev Yu.S. Kompleksnoe lechenie metastazov zlokachestvennykh opukholey v golovnoy mozg (khirurgicheskie aspekty): avtoref. dis. … d-ra med. nauk. M., 1996. 17. Sheehan J., Kondziolka D., Flickinger J., Lunsford L.D. Radiosurgery for patients with recurrent small cell lung carcinoma metastatic to the brain: outcomes and prognostic factors // J. Neurosurgery. 2005. V. 102 (Suppl.). P. 247-254. 18. Langley R.E., Stephens R.J., Nankivell M., Pugh C., Moore B., Nava- ni N., Wilson P., Faivre-Finn C., Barton R., Parmar M.K., Mulven- na P.M. QUARTZ Investigators. Interim data from the Medical Re-search Council QUARTZ Trial: does whole brain radiotherapy affect the survival and quality of life of patients with brain metastases from non-small cell lung cancer? // Clinical Trials. L.: The Royal College of Radiologists Unit, 2013. V. 25 (3). P. 23-30. 19. Nishizaki T., Saito K., Jimi Y., Harada N., Kajiwara K., Nomura S., Ishihara H., Yoshikawa K., Yoneda H., Suzuki M., Gibbs I.C. The role of cyberknife radiosurgery/radiotherapy for brain metastases of mul-tiple or large-size tumors // Minim. Invasive Neurosurg. 2006. V. 49. P. 203-209. 20. Kim C.H., Im Y.S., Nam D.H., Park K., Kim J.H., Lee J.I. Gamma knife radiosurgery for ten or more brain metastases // J. Korean Neurosurg Soc. 2008. V. 44. P. 358-363. 21. Guiqing Yang, Yishan Wang, Yuanyuan Wang, Sixiang Lun, Dongning Sun CyberKnife therapy of 24 multiple brain metastases from lung cancer: A case report // Oncol. Lett. 2013. V. 6 (2). P. 534-536.

Received

2015-09-10

Section of issue

Medicine

Для корректной работы сайта используйте один из современных браузеров. Например, Firefox 55, Chrome 60 или более новые.